Ezetimibe Uses
Links shared publicly online about this topic
Pulse - Concern over growing use of ezetimibe by GPs
pulsetoday.co.uk — “Pulse - Concern over growing use of ezetimibe by GPs” View full resource at pulsetoday.co.uk
Most Recently Shared on July 15, 2010 at 8:16 am By:
PulseToday Health News and Medical Publisher
Concern over growing use of ezetimibe by GPs: There is ‘no sound basis’ for the growing use of lipid-lowering drug... http://bit.ly/905QUm
Pulse - Concern over growing use of ezetimibe by GPs
pulsetoday.co.uk — “Pulse - Concern over growing use of ezetimibe by GPs” View full resource at pulsetoday.co.uk
Most Recently Shared on July 15, 2010 at 9:48 am By:
PulseToday Health News and Medical Publisher
Concern over growing use of ezetimibe by GPs: There is ‘no sound basis’ for the growing use of lipid-lowering drug... http://bit.ly/aBfd2N
Is prescribing of ezetimibe a rational use of NHS resources? NPCi blog - Jack's posterous
pharmagossip.posterous.com — “Is prescribing of ezetimibe a rational use of NHS resources? NPCi blog - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on August 17, 2010 at 3:46 pm By:
Jack Friday - PharmaGossip Health Blog
Is prescribing of ezetimibe a rational use of NHS resources? « NPCi blog http://post.ly/sILH
RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction
rxeconsult.com — “RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction” View full resource at rxeconsult.com
Most Recently Shared on September 20, 2011 at 11:58 am By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
Treating Coronary Heart Disease: Is Niaspan Better than Ezetimibe?
ethiopianreview.com — “By Simeon Margolis The media have given much attention to the results of a recent research study that looked at two drugs used to treat patients at high risk” View full resource at ethiopianreview.com
Most Recently Shared on January 2, 2010 at 5:58 am By:
low sodium foods Health Business
Treating Coronary Heart Disease: Is Niaspan Better than Ezetimibe? - Ethiopian Review http://bit.ly/5NiamK
Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) - FDA Investigates a Report from the SEAS Trial
fda.gov — “In august 2008, the u.s. food and drug administration (fda) issued an early communication describing a possible association between the use of vytorin – a combination of simvastatin (zocor) and ezetimibe (zetia) – and an increased risk of cancer and cancer-related death compared to placebo.” View full resource at fda.gov
Most Recently Shared on December 22, 2009 at 4:31 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDA_Drug_Info: Follow-Up to the Aug. 2008 Early Communication on Vytorin, Zetia, Zocor and the SEAS Trial. http://bit.ly/FU_SEAS
Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on July 13, 2009 at 1:28 pm By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Esetimibe vs niacin trial stopped, but not for safety reasons -will the cheap niacin be superior??? - http://bit.ly/xeRkx
70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial
businesswire.com — “CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial. The head-to-head trial demonstrated the superiority of extended-release niacin (Abbott) over ezetimibe (Merck’s Zetia) when combined with statin therapy. This data is part of Sermo’s ne” View full resource at businesswire.com
Most Recently Shared on December 1, 2009 at 1:59 pm By:
Sermo Team Health Social Media
"70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial" http://tinyurl.com/ygvbge3
70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial | Business Wire
businesswire.com — “CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial. The head-to-head trial demonstrated the superiority of extended-release niacin (Abbott) over ezetimibe (Merck’s Zetia) when combined with statin therapy. This data is part of Sermo’s ne” View full resource at businesswire.com
Most Recently Shared on December 2, 2009 at 3:03 pm By:
Fabio Gratton Health Social Media and Health Executive
Sermo publishes first report of new "FirstLine" series, revealing 70% of HCPs wld increase Niacin use based on trial data: http://tr.im/GpSJ
New Study Raises New Questions About Cholesterol Drug Zetia - Drugs.com MedNews
drugs.com — “A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or bad, cholesterol. The tr” View full resource at drugs.com
Most Recently Shared on November 16, 2009 at 6:10 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - http://bit.ly/ufFTI
New Study Raises New Questions About Cholesterol Drug Zetia - US News and World Report
health.usnews.com — “It was found less effective than extended-release niacin, or Niaspan” View full resource at health.usnews.com
Most Recently Shared on November 16, 2009 at 3:32 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - U.S. News & World Report http://ow.ly/1622kj
Study Raises New Questions About Cholesterol Drug Zetia - myOptumHealth
myoptumhealth.com — “Read the news article Study Raises New Questions About Cholesterol Drug Zetia at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 16, 2009 at 12:08 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia: It was found less effective than extended-release niac... http://bit.ly/28oBWa
Cardiology Article | Atherosclerosis
mdlinx.com — “The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 7:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at base... http://t.co/Lnolj9O #cardiology
Family Medicine Article | Atherosclerosis
mdlinx.com — “The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 8:54 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline:... http://t.co/2LDPHT1 #FamPractice
Endocrinology Article | Atherosclerosis
mdlinx.com — “The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline” View full resource at mdlinx.com
Most Recently Shared on September 9, 2011 at 7:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline: Athero... http://t.co/25Kfwzc #endo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
PulseToday
PulseToday.co.uk - Medical news, views, education and clinical information to GPs, nurses and other health professionals.
-
PulseToday
PulseToday.co.uk - Medical news, views, education and clinical information to GPs, nurses and other health professionals.
-
Jack Friday - PharmaGossip
A Big Pharma Insider. Any post may be a joke!
Advertisement
